Earnings Per Share, Diluted of Sonnet BioTherapeutics Holdings, Inc. from 31 Dec 2013 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Summary
Sonnet BioTherapeutics Holdings, Inc. quarterly and annual Earnings Per Share, Diluted in USD/shares history and change rate from 31 Dec 2013 to 30 Sep 2025.
  • Sonnet BioTherapeutics Holdings, Inc. Earnings Per Share, Diluted for the quarter ending 30 Sep 2025 was -0.55, a 86% increase year-over-year.
  • Sonnet BioTherapeutics Holdings, Inc. Earnings Per Share, Diluted for the twelve months ending 30 Sep 2025 was -3.95, a 65% increase year-over-year.
  • Sonnet BioTherapeutics Holdings, Inc. annual Earnings Per Share, Diluted for 2025 was -3.95, a 65% increase from 2024.
  • Sonnet BioTherapeutics Holdings, Inc. annual Earnings Per Share, Diluted for 2024 was -11.35, a 92% increase from 2023.
  • Sonnet BioTherapeutics Holdings, Inc. annual Earnings Per Share, Diluted for 2023 was -145, a 3.6% increase from 2022.
Source SEC data
View on sec.gov
Earnings Per Share, Diluted, Trailing 12 Months (USD/shares)
Earnings Per Share, Diluted, Quarterly (USD/shares)
Earnings Per Share, Diluted, YoY Quarterly Change (%)
Earnings Per Share, Diluted, Annual (USD/shares)
Earnings Per Share, Diluted, YoY Annual Change (%)

Sonnet BioTherapeutics Holdings, Inc. Quarterly Earnings Per Share, Diluted (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 -3.95 -0.55 +3.37 +86% 01 Jul 2025 30 Sep 2025 10-K 16 Dec 2025 2025 FY
Q2 2025 -7.32 -0.95 +4.62 +83% 01 Apr 2025 30 Jun 2025 10-Q 13 Aug 2025 2025 Q3
Q1 2025 -11.94 -0.89 -1.49 -248% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025 2025 Q2
Q4 2024 -10.45 -1.56 +0.9 +37% 01 Oct 2024 31 Dec 2024 10-Q 13 Feb 2025 2024 Q1
Q3 2024 -11.35 -3.92 +113 +97% 01 Jul 2024 30 Sep 2024 10-K 16 Dec 2025 2025 FY
Q2 2024 -124 -5.57 -2.62 -89% 01 Apr 2024 30 Jun 2024 10-Q 13 Aug 2025 2025 Q3
Q1 2024 -122 0.6 +8.15 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025 2025 Q2
Q4 2023 -130 -2.46 +15.16 +86% 01 Oct 2023 31 Dec 2023 10-Q 13 Feb 2025 2024 Q1
Q3 2023 -145 -117 01 Jul 2023 30 Sep 2023 10-K 17 Dec 2024 2024 FY
Q2 2023 -2.95 -1.13 -62% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024 2024 Q3
Q1 2023 -7.55 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q2
Q4 2022 -17.62 01 Oct 2022 31 Dec 2022 10-Q 14 Feb 2024 2024 Q1
Q2 2022 -1.82 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q3
Q2 2015 0 +0.01 01 Apr 2015 30 Jun 2015 10-Q 14 Aug 2015 2015 Q2
Q1 2015 0 +0.01 01 Jan 2015 31 Mar 2015 10-Q 20 May 2015 2015 Q1
Q2 2014 -0.01 01 Apr 2014 30 Jun 2014 10-Q 16 Nov 2015 2015 Q3
Q1 2014 -0.01 01 Jan 2014 31 Mar 2014 10-Q 20 May 2015 2015 Q1

Sonnet BioTherapeutics Holdings, Inc. Annual Earnings Per Share, Diluted (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 -3.95 +7.4 +65% 01 Oct 2024 30 Sep 2025 10-K 16 Dec 2025 2025 FY
2024 -11.35 +134 +92% 01 Oct 2023 30 Sep 2024 10-K 16 Dec 2025 2025 FY
2023 -145 +5.39 +3.6% 01 Oct 2022 30 Sep 2023 10-K 17 Dec 2024 2024 FY
2022 -151 01 Oct 2021 30 Sep 2022 10-K 14 Dec 2023 2023 FY
2015 0 +0.15 01 Jan 2015 31 Dec 2015 10-K 31 Mar 2016 2015 FY
2014 -0.15 -0.14 -1400% 01 Jan 2014 31 Dec 2014 10-K 31 Mar 2016 2015 FY
2013 -0.01 01 Jan 2013 31 Dec 2013 10-K 15 Apr 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.